Patient’s Journey

This initial phase is about finding a study that might be the right fit for you.

• Discovering the Study: You will typically learn about a new research study through your treating physician, a hospital, or a patient advocacy group.
• Initial Check: You express your interest and answer a few basic questions about your health, medical history, and specific condition. This helps us quickly determine if you meet the preliminary requirements for the study.

This is the most critical step, where we ensure you have comprehensive information to make an educated decision.

• Understanding the Facts: A dedicated member of our clinical team will meet with you to thoroughly explain the study’s purpose, the treatment being tested, all known potential risks and benefits, and the complete schedule of procedures and visits. All your questions will be answered.
• Your Freedom to Choose: You will be clearly informed that participation is completely voluntary. You maintain the absolute right to withdraw from the study at any time, for any reason, without it affecting your regular medical care or relationship with your doctor.
• Signing the Form: If you agree to move forward, you will sign the Informed Consent Form (ICF). This document is not a contract; it is your written confirmation that you understand and agree to the research plan.
• Ethics Review: Be assured that an independent group of experts, called an Ethics Committee or Institutional Review Board (IRB), has already reviewed and approved the entire study plan to ensure it is ethical and safe for patients.

This phase confirms that the study is medically suitable and safe for you.

• Testing and Review: You will undergo a series of medical exams, blood tests, and other specific procedures (like scans or comprehensive history review). This step is necessary to confirm you meet all the strict eligibility criteria required by the study protocol.
• Final Decision: The study doctor (Principal Investigator) reviews all the results to make the final determination on whether you are safe and suitable to participate.

If you are eligible, the main part of the trial begins.

• Treatment Assignment: You will start receiving the investigational treatment. Depending on the trial, this may be the new medication, a standard treatment, or a placebo (an inactive substance used in blinded studies).
• Regular Visits: You will attend scheduled appointments at the clinical research site. These visits are essential for:
  • Receiving your medication.
  • Undergoing specific tests (like blood draws or physical exams) to check the treatment’s effect on your body.
  • Monitoring your health for any changes or side effects.
• Your Safety is Our Priority: Adverse Events: As a participant, you can expect the highest standards of care. Our experienced team closely monitors you throughout the study. A key part of this is the careful tracking of any “Adverse Events” (AEs)—any unexpected or undesirable medical occurrence you experience during the trial. It is crucial to report any new or worsening symptoms, no matter how minor, to our team immediately. You can contact our dedicated 24/7 Safety Hotline for prompt reporting.
• Confidentiality: Your privacy is paramount. All your personal and medical information is kept strictly private and confidential, adhering to stringent national and international data protection measures.